Ikarian Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5M | Buy |
56,594
+25,000
| +79% | +$8.15M | 3.54% | 2 |
|
|
2025
Q1 | $8.53M | Buy |
+31,594
| New | +$8.53M | 1.05% | 7 |
|
|
2024
Q4 | – | Sell |
-8,741
| Closed | -$2.4M | – | 124 |
|
|
2024
Q3 | $2.4M | Buy |
+8,741
| New | +$2.4M | 0.34% | 38 |
|
|
2024
Q2 | – | Sell |
-51,541
| Closed | -$7.7M | – | 86 |
|
|
2024
Q1 | $7.7M | Buy |
+51,541
| New | +$7.7M | 0.84% | 16 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 81 |
|
|
2022
Q4 | – | Sell |
-2,800
| Closed | -$560K | – | 68 |
|
|
2022
Q3 | $560K | Sell |
2,800
-58,437
| -95% | -$11.7M | 0.11% | 44 |
|
|
2022
Q2 | $8.93M | Buy |
61,237
+60,000
| +4,850% | +$8.75M | 1.63% | 10 |
|
|
2022
Q1 | $201K | Buy |
1,237
+42
| +4% | +$6.83K | 0.03% | 127 |
|
|
2021
Q4 | $204K | Sell |
1,195
-266
| -18% | -$45.4K | 0.03% | 122 |
|
|
2021
Q3 | $276K | Buy |
+1,461
| New | +$276K | 0.02% | 134 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 160 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 183 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 139 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 106 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 89 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 79 |
|